← Back to Search

Educational Material for Cervical Cancer Screening Adherence

N/A
Waitlist Available
Led By Lindsay M Kuroki, M.D.
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to create an educational program to help patients better understand cervical cancer prevention and improve their adherence to colposcopy. #CervicalCancer

Who is the study for?
This trial is for individuals aged 21 or older who have had an abnormal cervical screening and are referred to the WUSM colposcopy clinic. It's not open to those who cannot consent or have a history of cervical cancer.
What is being tested?
The study is testing patient-centered educational materials designed to improve understanding and adherence to colposcopy procedures, which are important in preventing cervical cancer.
What are the potential side effects?
Since this trial involves educational material rather than medical treatment, there are no direct side effects associated with it.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in participant knowledge of colposcopy
Secondary study objectives
Acceptability of educational material as measured by the Acceptability of Intervention Measure
Appropriateness of educational material as measured by the Intervention Appropriateness Measure
Number of participants who stated that the educational material will influence their intention to adhere to colposcopy

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Colposcopy educational materialExperimental Treatment1 Intervention
Participants will complete a 9-question quiz that will assess knowledge of colposcopy. They will then view the colposcopy educational material and answer the same 9-question quiz to assess their knowledge of colposcopy. Participants will complete the Acceptability Intervention Measure, the Intervention Appropriateness Measure, and the Feasibility of Intervention Measure. Participants will also be asked whether the educational material influences their intention to adhere to colposcopy.

Find a Location

Who is running the clinical trial?

American Association of Obstetricians and GynecologistsUNKNOWN
Washington University School of MedicineLead Sponsor
1,991 Previous Clinical Trials
2,295,835 Total Patients Enrolled
Lindsay M Kuroki, M.D.Principal InvestigatorWashington University School of Medicine
2 Previous Clinical Trials
177 Total Patients Enrolled

Media Library

Colposcopy educational material Clinical Trial Eligibility Overview. Trial Name: NCT05762757 — N/A
Cervical Cancer Screening Research Study Groups: Colposcopy educational material
Cervical Cancer Screening Clinical Trial 2023: Colposcopy educational material Highlights & Side Effects. Trial Name: NCT05762757 — N/A
Colposcopy educational material 2023 Treatment Timeline for Medical Study. Trial Name: NCT05762757 — N/A
~14 spots leftby Nov 2025